Brigham and Women s Hospital,
(United States of America)
Risk Factors and Prevention
Acute Coronary Syndromes, Pharmacology and Pharmacotherapy, Risk Factors and Prevention
Follow me on:
Christopher P. Cannon, MD
Cardiovascular Innovation, Brigham and Women’s Hospital
Professor of Medicine, Harvard Medical School, Boston, MA
Dr. Cannon is a Professor of Medicine at Harvard Medical School, and senior physician in the Cardiovascular Division at Brigham and Women’s Hospital. He currently serves as Education Director in the Cardiovascular Innovation group.
He has worked for 25 years as an investigator in the TIMI Study Group. He has been principal investigator of more than 20 multicenter clinical trials, including TACTICS-TIMI 18, PROVE IT, IMPROVE IT, and RE-DUAL PCI trials. In his role at Cardiovascular Innovation, he is helping implement quality improvement program 'Remote Health' for lipids and hypertension.
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.
Our mission: To reduce the burden of cardiovascular disease